Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;11(6):508-18.
doi: 10.2174/138955711795843374.

New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia

L Laurenti  1 , L De Padua, G D'Arena, B Vannata, I Innocenti, M Tarnani, S Deaglio, S Sica, D G Efremov, G Leone
Affiliations

New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia

L Laurenti et al. Mini Rev Med Chem. 2011 Jun.

Abstract

Over the last few years, several new agents have been under evaluation in preclinical studies and clinical trials, showing promise in treating chronic lymphocytic leukemia (CLL). Among these agents, monoclonal antibodies (mAbs) such as rituximab and alemtuzumab have changed the natural course of the disease. Nowadays there are several new promising monoclonal antibodies under investigation against the CD20, CD23, CD37 and CD40 molecules. Application of newer monoclonal antibodies represents an area of ongoing clinical research in CLL.

PubMed Disclaimer

MeSH terms